Bg pattern

VANIQA 11.5% CREAM

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use VANIQA 11.5% CREAM

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Vaniqa 11.5% Cream

Eflornithine

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the package leaflet:

  1. What is Vaniqa and what is it used for
  2. What you need to know before you use Vaniqa
  1. How to use Vaniqa
  2. Possible side effects

5 Storage of Vaniqa

  1. Contents of the pack and further information

1. What is Vaniqa and what is it used for

Vaniqa contains the active substance eflornithine. Eflornithine delays hair growth by its effect on a specific enzyme (a protein in the body involved in hair formation).

Vaniqa is used to reduce excessive hair growth (hirsutism) on the face in women over 18 years of age.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you use Vaniqa

Do not use Vaniqa:

  • if you are allergic to eflornithine or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Consult your doctor or pharmacist before starting to use Vaniqa

  • tell your doctor about any other medical problems you are experiencing (especially those related to your kidneys or liver)

Excessive hair growth can be caused by underlying diseases. Consult your doctor if you have polycystic ovary syndrome (PCOS) or hormone-producing tumors, or if you are taking medications that can induce hair growth, such as cyclosporin (after organ transplantation), glucocorticoids (e.g. for rheumatic or allergic diseases), minoxidil (for hypertension), phenobarbital (for seizures), or phenytoin (for seizures) or hormone replacement therapy with similar effects to male hormones.

Girls and adolescents

Vaniqa is notrecommended for use in persons under 18 years of age.

Other medicines and Vaniqa

Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines, including those obtained without a prescription.

Consult your doctor if you need to use other medicines on the skin areas where you are using the cream.

Pregnancy and breast-feeding

Do not use this medicine if you are pregnant or breast-feeding. You should use an alternative method to treat your facial hair if you are pregnant or think you may be pregnant.

Driving and using machines

Vaniqa is not expected to affect your ability to drive or use machines.

Vaniqa contains cetyl alcohol and stearyl alcoholwhich may cause local skin reactions (e.g. contact dermatitis). Vaniqa also contains methyl parahydroxybenzoate (E218) and propyl parahydroxybenzoate (E216)which may cause allergic reactions (possibly delayed).

3. How to use Vaniqa

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

Follow exactly the instructions of administration of this medicine indicated by your doctor.

In case of doubt, consult your doctor or pharmacist again.

  • Use it twice a day, leaving a space of at least 8 hours.
  • If you experience irritation (e.g. stinging), reduce the use of Vaniqa to once a day until the irritation has passed. If it persists, contact your doctor.
  • If you have shaved or used any other hair removal method, you should wait at least 5 minutesbefore using Vaniqa. It may sting or burn if applied to cut or irritated skin.
  • Clean and dry the skin areas before applying the cream.
  • Apply a thin layer of cream and massage it in until no visible residue of the product remains on the treated areas.
  • Whenever possible, do notwash these skin areas during the 4 hours following application of the cream.
  • Wash your hands after applying the cream.
  • Wait at least 5 minutesbefore using makeup or sunscreens on the same areas.
  • When using on the face, avoidcontact with the eyes or the inside of the nose or mouth. If Vaniqa accidentally gets into your eyes, mouth, or nose, rinse well with water.

Vaniqa is nota hair removal cream, so you may need to continue with the method you use to remove hair, such as shaving or depilatory creams.

It may take up to 8 weeks before results are visible. It is important to continue using the cream. If you do not see any improvement after using it for 4 months, consult your doctor. If you stop using it, your original hair growth may return within 8 weeks.

If you use more Vaniqa than you should

If too much cream is applied to the skin, it is unlikely to harm you.

If you or someone else accidentally ingests Vaniqa, tell your doctor.

If you forget to use Vaniqa

Apply it as soon as you remember, but wait at least 8 hours before using it again.

If you interrupt treatment with Vaniqa

To maintain the reduction of hair growth, continue using Vaniqa as directed.

If you have any other questions about the use of this product, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Side effects are usually limited to the skin and are mild. In such cases, they usually resolve without interruption of treatment with Vaniqa.

The frequency of possible side effects listed below is defined using the following convention:

very common (affects more than 1 user in 10)

common (affects 1 to 10 users in 100)

uncommon (affects 1 to 10 users in 1,000)

rare (affects 1 to 10 users in 10,000)

very rare (affects less than 1 user in 10,000)

frequency not known (cannot be estimated from the available data).

Very common (affects more than 1 user in 10)

  1. acne

Common (affects 1 to 10 users in 100)

  • dry skin
  • hair loss
  • inflammation around the pore
  • itching
  • rash
  • redness
  • skin irritation and bumps caused by shaving
  • skin irritation
  • burning, itching, or tingling sensation of the skin

Uncommon (affects 1 to 10 users in 1,000)

  • papular rash
  • cold sore
  • redness and irritation at the site of application of the cream
  • eczema
  • inflamed, numb, cracked, or dry lips
  • ingrown hairs
  • pale areas of skin
  • skin bleeding
  • skin furuncles
  • skin redness
  • skin inflammation
  • skin ulcers
  • swelling of the mouth or face
  1. abnormal hair texture or abnormal hair growth

Rare (affects 1 to 10 users in 10,000)

  • abnormal skin growth (skin neoplasia)
  • excessive hair growth
  • facial redness and pimples possibly with pus
  • other skin disorders
  • inflammation and redness of the skin with scaling and itching (seborrhoeic dermatitis)
  • rash with redness, bumps, or blisters
  • skin cysts
  • skin tightness

Reporting of side effects

If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Vaniqa

Keep this medicine out of the sight and reach of children.

Do notuse this medicine after the expiry date which is stated on the carton and on the bottom of the tube after EXP. The expiry date is the last day of the month stated.

Once opened, discard the tube with the remaining cream after 6 months.

Make sure to close the tube cap tightly after each use.

Do notstore above 25°C.

Medicines should notbe disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Contents of the pack and further information

Composition of Vaniqa

The active substance is eflornithine.

Each gram of cream contains 115 mg of eflornithine (as monohydrochloride).

The other ingredients are:

Cetyl alcohol, macrogol cetostearyl ether, dimeticone, glyceryl stearate, macrogol stearate, methyl parahydroxybenzoate (E218), liquid paraffin, phenoxyethanol, propyl parahydroxybenzoate (E216), purified water, and stearyl alcohol. Occasionally, very small amounts of sodium hydroxide (E524) are added to maintain normal acidity levels (pH levels).

Appearance and pack size of the product

Vaniqa is a white to off-white cream. It is available in tubes of 15 g, 30 g, and 60 g, but not all pack sizes may be marketed.

Marketing authorisation holder

Almirall, S.A.

Ronda General Mitre, 151

08022 Barcelona

Spain

Tel.: +34 93 291 30 00

Manufacturer

Almirall Hermal GmbH

Scholtzstrasse 3

D-21465 Reinbek

Germany

You can obtain further information on this medicine from the local representative of the marketing authorisation holder.

Belgique/België/Belgien

Almirall N.V.

Tél/Tel: +32 (0)2 771 86 37

Ireland

Almirall ApS

Tel.: +45 70 25 75 75

???????? / Ceská republika / Hrvatska / Eesti / Ελλ?δα / España / Κ?προς / Latvija / Lietuva / Magyarország / Malta / România / Slovenija / Slovenská republika

Almirall, S.A.

Te?/Tel/Tlf/Tηλ/Sími: +34 93 291 30 00

Nederland

Almirall BV

Tel.: +31 (0) 307991155

Deutschland

Luxembourg/Luxemburg

Almirall Hermal GmbH

Tel./ Tél: +49 (0)40 72704-0

Österreich

Almirall GmbH

Tel.: +43 01/595 39 60

Danmark / Ísland / Norge / Suomi/Finland / Sverige

Almirall ApS

Tel./Puh.: +45 70 25 75 75

Polska

Almirall Sp. z o.o.

Tel.: +48 22 330 02 57

France

Almirall SAS

Tél.: +33(0)1 46 46 19 20

Portugal

Almirall - Produtos Farmacêuticos, Lda.

Tel.: +351 21 415 57 50

Italia

Almirall SpA

Tel.: +39 02 346181

United Kingdom

Almirall Limited

Tel.: +44 (0) 800 0087399

Date of last revision of this leaflet:

Detailed information on this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu

Online doctors for VANIQA 11.5% CREAM

Discuss questions about VANIQA 11.5% CREAM, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (7)
Doctor

Anastasiia Hladkykh

Psychiatry 15 years exp.

Dr Anastasiia Hladkykh is a physician-psychotherapist and psychologist with over 14 years of experience working with individuals struggling with various types of addictions and their families. She provides online consultations for adults, combining medical knowledge with deep psychological support and practical tools.

Key areas of expertise:

  • Addiction treatment: alcohol and drug dependence, gambling addiction, compulsive behaviours, codependent relationships.
  • Support for families of addicted individuals, behavioural correction within the family system, guidance for maintaining remission.
  • Mental health: depression, bipolar disorder, obsessive-compulsive disorder (OCD), anxiety disorders, phobias, PTSD, generalised anxiety, emotional trauma, and the psychological impact of loss or emigration.
  • Psychoeducation: explaining complex mental health concepts in simple language, helping patients and their families understand diagnoses and treatment steps.
Therapeutic approach:
  • Client-centred, straightforward, and empathetic – focused on practical outcomes and emotional stabilisation.
  • Prescribes medications when needed, but always aims to minimise unnecessary pharmaceutical use.
  • Certified in multiple evidence-based methods: CBT, NLP (Master Practitioner), Ericksonian hypnosis, symbol drama, art therapy, and systemic therapy.
  • Each consultation results in a clear, structured plan – patients leave knowing exactly what to do next.
Experience and background:
  • Member of the German association Gesundheitpraktikerin and the NGO “Mit dem Sonne in jedem Herzen.”
  • More than 18 publications in international peer-reviewed journals, translated into several languages.
  • Volunteer work with Ukrainian refugees and military personnel at the University Clinic of Regensburg.
Camera Book a video appointment
€130
5.0 (144)
Doctor

Yevgen Yakovenko

General surgery 12 years exp.

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

  • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
  • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
  • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
  • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
  • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
  • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
  • Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
  • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
  • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

  • 12+ years of clinical experience in university hospitals in Germany and Spain.
  • International education: Ukraine – Germany – Spain.
  • Member of the German Society of Surgeons (BDC).
  • Certified in radiological diagnostics and robotic surgery.
  • Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

Camera Book a video appointment
€50
5.0 (2)
Doctor

Svetlana Kolomeeva

Cardiology 18 years exp.

Dr. Svetlana Kolomeeva is a general practitioner and internal medicine doctor providing online consultations for adults. She helps patients manage acute symptoms, chronic conditions, and preventive care. Her clinical focus includes cardiovascular health, hypertension control, and managing symptoms like fatigue, weakness, sleep issues, and overall low energy.

Patients commonly seek her help for:

  • High blood pressure, headaches, dizziness, swelling, palpitations.
  • Diagnosis and management of hypertension, arrhythmias, and tachycardia.
  • Metabolic syndrome, excess weight, high cholesterol.
  • Chronic fatigue, insomnia, poor concentration, anxiety.
  • Respiratory symptoms: colds, flu, sore throat, cough, fever.
  • Digestive issues: heartburn, bloating, constipation, IBS symptoms.
  • Chronic conditions: diabetes, thyroid disorders.
  • Interpretation of lab tests and medical reports, therapy adjustment.
  • Second opinion and decision-making support.
  • Cardiovascular disease prevention and metabolic risk reduction.
  • Long-term follow-up and dynamic health monitoring.

Dr Kolomeeva combines clinical expertise with personalised care. She clearly explains diagnoses, guides patients through symptoms and treatment options, and provides actionable plans. Her consultations are designed not only to address current complaints but also to stabilise chronic conditions and prevent future complications. She supports patients through every stage of care – from first symptoms to ongoing health management.

Camera Book a video appointment
€55
...
4

Frequently Asked Questions

Is a prescription required for VANIQA 11.5% CREAM?
VANIQA 11.5% CREAM requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
Who manufactures VANIQA 11.5% CREAM?
VANIQA 11.5% CREAM is manufactured by Almirall S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of VANIQA 11.5% CREAM online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether VANIQA 11.5% CREAM is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to VANIQA 11.5% CREAM?
Other medicines with the same active substance () include ALOCARE 1 mg FILM-COATED TABLETS, ALOCARE 2.275 mg/ml CUTANEOUS SPRAY SOLUTION, ALOCUTAN 50 mg/ml CUTANEOUS SPRAY SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media